Clinical Trials in Illinois

Showing 5781-5800 of 19,692 trials

Testing a Family Service Navigator Program for Low-resourced Families of Young Children with Autism Spectrum Disorder

NCT05099705

The purpose of this study is to develop and test a family navigator training and an app (a technology-based treatment support system) for low-resourced families of young children (aged 3-5) with autism. The hypothesis is that the navigator training and treatment support system will help enable navigators to support families of young children with autism in accessing needed services.

Autism Spectrum DisorderMental Health Services

Vanderbilt University55 participantsStarted Jul 2022

Champaign, Illinois, United States

COMPLETEDPhase 2125 miles

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

NCT02222155

The aim of this trial is to test the safety and efficacy of two dose regimens of the complement C5a receptor CCX168 in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Funding Source - FDA OOPD

ANCA-associated Vasculitis

Amgen42 participantsStarted Feb 2015

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +40 more locations

Testing a Family Service Navigator Program for Low-resourced Families of Young Children with Autism Spectrum Disorder

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

Find Trials by Condition in Illinois

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

Brain Injury Rehabilitation Improving the Transition Experience

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

SNV1521 in Participants with Advanced Solid Tumors

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Intervention to Enhance PrEP Persistence

Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial